Nayak S, Norris JD, Ammirante M, Rychak E, et al. Discovery of BMS-986365, a first-in-class dual androgen receptor ligand-directed degrader (AR LDD) and antagonist, for the treatment of advanced prostate cancer. Clin Cancer Res 2025 Aug 11. doi: 10.1158/1078-0432.CCR-25-0471.
PMID: 40788283